202 related articles for article (PubMed ID: 33772041)
1. Predicting amyloid positivity in patients with mild cognitive impairment using a radiomics approach.
Kim JP; Kim J; Jang H; Kim J; Kang SH; Kim JS; Lee J; Na DL; Kim HJ; Seo SW; Park H
Sci Rep; 2021 Mar; 11(1):6954. PubMed ID: 33772041
[TBL] [Abstract][Full Text] [Related]
2. Predicting Amyloid Pathology in Mild Cognitive Impairment Using Radiomics Analysis of Magnetic Resonance Imaging.
Park YW; Choi D; Park M; Ahn SJ; Ahn SS; Suh SH; Lee SK;
J Alzheimers Dis; 2021; 79(2):483-491. PubMed ID: 33337361
[TBL] [Abstract][Full Text] [Related]
3. Do radiomics or diffusion-tensor images provide additional information to predict brain amyloid-beta positivity?
Jo S; Lee H; Kim HJ; Suh CH; Kim SJ; Lee Y; Roh JH; Lee JH
Sci Rep; 2023 Jun; 13(1):9755. PubMed ID: 37328578
[TBL] [Abstract][Full Text] [Related]
4. MRI Radiomics Classification and Prediction in Alzheimer's Disease and Mild Cognitive Impairment: A Review.
Feng Q; Ding Z
Curr Alzheimer Res; 2020; 17(3):297-309. PubMed ID: 32124697
[TBL] [Abstract][Full Text] [Related]
5. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.
Da X; Toledo JB; Zee J; Wolk DA; Xie SX; Ou Y; Shacklett A; Parmpi P; Shaw L; Trojanowski JQ; Davatzikos C;
Neuroimage Clin; 2014; 4():164-73. PubMed ID: 24371799
[TBL] [Abstract][Full Text] [Related]
6. Predicting amyloid positivity from FDG-PET images using radiomics: A parsimonious model.
Rasi R; Guvenis A;
Comput Methods Programs Biomed; 2024 Apr; 247():108098. PubMed ID: 38442621
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
[TBL] [Abstract][Full Text] [Related]
8. Radiomics signature of brain metastasis: prediction of EGFR mutation status.
Wang G; Wang B; Wang Z; Li W; Xiu J; Liu Z; Han M
Eur Radiol; 2021 Jul; 31(7):4538-4547. PubMed ID: 33439315
[TBL] [Abstract][Full Text] [Related]
9. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
[TBL] [Abstract][Full Text] [Related]
10. Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disorders.
Momota Y; Bun S; Hirano J; Kamiya K; Ueda R; Iwabuchi Y; Takahata K; Yamamoto Y; Tezuka T; Kubota M; Seki M; Shikimoto R; Mimura Y; Kishimoto T; Tabuchi H; Jinzaki M; Ito D; Mimura M
Sci Rep; 2024 Apr; 14(1):7633. PubMed ID: 38561395
[TBL] [Abstract][Full Text] [Related]
11. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Cognitive Progression in Individuals with Mild Cognitive Impairment Using Radiomics as an Improvement of the ATN System: A Five-Year Follow-Up Study.
Song R; Wu X; Liu H; Guo D; Tang L; Zhang W; Feng J; Li C
Korean J Radiol; 2022 Jan; 23(1):89-100. PubMed ID: 34983097
[TBL] [Abstract][Full Text] [Related]
13. Machine Learning for the Prediction of Amyloid Positivity in Amnestic Mild Cognitive Impairment.
Kang SH; Cheon BK; Kim JS; Jang H; Kim HJ; Park KW; Noh Y; Lee JS; Ye BS; Na DL; Lee H; Seo SW
J Alzheimers Dis; 2021; 80(1):143-157. PubMed ID: 33523003
[TBL] [Abstract][Full Text] [Related]
14. Neuroimaging predictors of brain amyloidosis in mild cognitive impairment.
Tosun D; Joshi S; Weiner MW;
Ann Neurol; 2013 Aug; 74(2):188-98. PubMed ID: 23686534
[TBL] [Abstract][Full Text] [Related]
15. Relationship of Hippocampal Volume to Amyloid Burden across Diagnostic Stages of Alzheimer's Disease.
Trzepacz PT; Hochstetler H; Yu P; Castelluccio P; Witte MM; Dell'Agnello G; Degenhardt EK;
Dement Geriatr Cogn Disord; 2016; 41(1-2):68-79. PubMed ID: 26625159
[TBL] [Abstract][Full Text] [Related]
16. Considerable effects of imaging sequences, feature extraction, feature selection, and classifiers on radiomics-based prediction of microvascular invasion in hepatocellular carcinoma using magnetic resonance imaging.
Dai H; Lu M; Huang B; Tang M; Pang T; Liao B; Cai H; Huang M; Zhou Y; Chen X; Ding H; Feng ST
Quant Imaging Med Surg; 2021 May; 11(5):1836-1853. PubMed ID: 33936969
[TBL] [Abstract][Full Text] [Related]
17. An investigation of machine learning methods in delta-radiomics feature analysis.
Chang Y; Lafata K; Sun W; Wang C; Chang Z; Kirkpatrick JP; Yin FF
PLoS One; 2019; 14(12):e0226348. PubMed ID: 31834910
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors Predicting Amyloid PET Positivity in Patients with Mild Cognitive Impairment and Apolipoprotein E ɛ3/ɛ3 Genotypes.
Ho SH; Yang DW
J Alzheimers Dis; 2020; 77(3):1017-1024. PubMed ID: 32804143
[TBL] [Abstract][Full Text] [Related]
20. Individualized Prediction of Early Alzheimer's Disease Based on Magnetic Resonance Imaging Radiomics, Clinical, and Laboratory Examinations: A 60-Month Follow-Up Study.
Tang L; Wu X; Liu H; Wu F; Song R; Zhang W; Guo D; Feng J; Li C
J Magn Reson Imaging; 2021 Nov; 54(5):1647-1657. PubMed ID: 33987915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
